In 2023, Germany led the European sold production of laboratory, hygienic, or pharmaceutical glassware with 296.89 million euros, followed by France (35.694 million euros) and the United Kingdom (20.539 million euros). Croatia (13.413 million euros) outpaced Portugal and Romania. Observing trends, Germany and Spain showed positive year-on-year growth of 4.09% and 3.97%, respectively. Conversely, the United Kingdom declined by 9.0%, indicating potential challenges. France experienced a slight decrease of 0.26%, while Croatia, Portugal, and Romania saw modest growth at 2.25%, 3.74%, and 1.65%, respectively.
Looking forward, the European market for laboratory, hygienic, or pharmaceutical glassware is likely to be influenced by technological advancements, sustainability initiatives, and varying economic conditions across countries. Germany's continued dominance may persist with its strong industrial base, while countries like Spain and Portugal might benefit from increased investments and innovation. Monitoring these dynamics will provide insights into future production and market shifts.
Top countries in Sold Production of Laboratory, Hygienic or Pharmaceutical Glassware Whether or Not Graduated by Country
| # | 8 Countries | Euros | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 296,890,000 | 2023 | +1.11% | +4.09% | View data |
| 2 | 2 France | 35,694,000 | 2023 | +0.5% | -0.26% | View data |
| 3 | 3 United Kingdom | 20,539,000 | 2023 | -3.42% | -9% | View data |
| 4 | 4 Spain | 16,780,000 | 2023 | +3.04% | +3.97% | View data |
| 5 | 5 Czechia | 16,773,000 | 2023 | |||
| 6 | 6 Croatia | 13,413,000 | 2023 | +1.55% | +2.25% | View data |
| 7 | 7 Portugal | 4,588,200 | 2023 | +8.51% | +3.74% | View data |
| 8 | 8 Romania | 828,200 | 2023 | +2.37% | +1.65% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...